$TMDX
TransMedics Group, Inc. Common Stock
XNAS•Health Care•Electromedical & Electrotherapeutic Apparatus
$86.42
▼-0.27%-$0.237
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateTransMedics Group, Inc. Common Stock
XNAS•Health Care•Electromedical & Electrotherapeutic Apparatus
Why is TMDX down today? It is at $86.42 (-0.27%), and our scanner flagged it 78 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment TMDX spikes, and full due diligence on TMDX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $TMDX 78 times in the last 30 days. Create a free account to track $TMDX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on TMDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TMDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystTransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial OutlookReported $16 billion segment combining GE HealthCare’s Imaging and Advanced Visualization Solutions businesses with its global Integrated Supply Chain and Global Service organizations. He previously served as GE HealthCare’s CorporateReported TransMedics is reiterating its full-year 2026 revenue guidance of $737 million to $757 million, representing approximately 22% to 25% year-over-year, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 14, 2026 · 5 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Weill David Director | Bought (open market) | +1K | added 8.9% | 16K | $109K at $81.63 | Sep 11, 26 |
Tobin James R Director | Sold (automatic/other) | -18K 0.05% of company | sold 10% | 155K | n/a | Aug 17, 26 |
Hassanein Waleed H Officer | Acquired (grant/award) | +50K 0.1% of company | added 41% | 171K | n/a | Jul 10, 26 |
Hernandez Gerardo Officer | Acquired (grant/award) | +17K 0.05% of company | added 100% | 32K | n/a | Jul 10, 26 |
Corcoran Nicholas Officer | Acquired (grant/award) | +12K 0.03% of company | added 39% | 42K | n/a | Jul 10, 26 |
Gunderson Thomas J. Director | Sold (automatic/other) | -10K 0.03% of company | sold 37% | 17K | $722K at $75.06 | Jun 15, 26 |
Gunderson Thomas J. Director | Other | 19K 0.06% of company | added 100% | 26K | $43K at $2.21 | Jun 15, 26 |
Kania Edwin Director | Acquired (grant/award) | +3K | added 1.1% | 264K | n/a | May 20, 26 |
Tobin James R Director | Acquired (grant/award) | +3K | added 72% | 7K | n/a | May 20, 26 |
Basile Edward M Director | Acquired (grant/award) | +3K | added 100% | 6K | n/a | May 20, 26 |
Gunderson Thomas J. Director | Acquired (grant/award) | +3K | added 72% | 7K | n/a | May 20, 26 |
Raines Merilee Director | Acquired (grant/award) | +3K | added 72% | 7K | n/a | May 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in electromedical & electrotherapeutic apparatus, closest in size first.
Here is the latest on TMDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for TMDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
TMDX last traded at $86.42, down 0.27% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
TransMedics Group, Inc. Common Stock (TMDX) is next expected to report earnings on Wednesday, November 4, 2026, about 45 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The TMDX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged TMDX 78 times in the last 30 days.
TMDX (TransMedics Group, Inc. Common Stock) trades on XNAS, with a market cap of about $3.00B in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge TMDX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$TMDX discussion
Sign in to ask a question or join the discussion.